Unleash Massive Protein Yields and Cost Savings in Your Production with Sirius Proteins
Enhance your efficiency, reduce costs, and simplify complex protein production with patented technology from Sirius Proteins.
About Us
Who We Are
Sirius Proteins is transforming the landscape of protein production with groundbreaking bacterial expression technology. With a commitment to efficiency, innovation, and cost-effectiveness, we provide large-scale manufacturers across the biotech, health, food, cosmetics, and energy sectors with the tools they need to enhance their protein yields, simplify production processes, and expand their manufacturing potential.
Our patented technology is designed to address the complexities and limitations of traditional protein production, enabling high yields, lower costs, and unprecedented flexibility.
The Problem
Challenges in Protein Production
Many organizations face significant challenges in scaling recombinant protein production due to low yields in bacterial systems, the high costs of using mammalian cells for complex proteins, labor-intensive purification processes, and limitations in producing toxic or complex proteins.
These issues increase costs and slow down time-to-market, hindering efficiency and scalability across industries.
Our Solution
Our Breakthrough Solution for Scalable Protein Production
Sirius Proteins offers advanced bacterial expression technology to overcome key production challenges, enabling up to 100-fold increases in protein yields without extra facility space. Our system allows efficient production of complex proteins, like disulphide-bonded antibodies, in E. coli—cutting costs tied to mammalian cells.
We streamline purification by isolating vesicle-packaged proteins directly from culture media and enable safe production of traditionally toxic proteins. With Sirius Proteins, manufacturers gain a more efficient, versatile, and scalable protein production process.
Sirius Proteins
Our Features
Unmatched Protein Yields
Boost yields up to 100-fold, maximising output without expanding facility space.
Efficient Disulphide-Bonded Protein Production
Produce functional antibodies and other complex proteins in E. coli, reducing dependency on expensive mammalian cells.
Streamlined Purification
Simplify purification and reduce costs by isolating vesicle-packaged proteins directly from culture media.
Expanded Production Flexibility
Safely produce proteins traditionally toxic to bacterial cells, broadening manufacturing capabilities.
FAQS
Frequently Asked Questions
How predictable are expression and yield outcomes with this technology?
Our technology has consistently shown success across 100% of proteins tested (n=200). However, results may vary depending on specific proteins, which is why we offer proof-of-concept studies to evaluate the potential performance in your operations.
Is bacterial production safe for food and therapeutic applications?
Yes, Sirius Proteins uses non-pathogenic bacterial strains and offers options with low endotoxin content to align with stringent safety standards in the food and therapeutic industries.
Ready to Boost Your Production?
Fill out the form to request a proof-of-concept study or learn more about integrating Sirius Proteins’ technology into your facility.